“hypercoagulable”的搜索结果，显示 1111-1120 项，共有 10391 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer.

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B ...

5. 食管 - 妙佑医疗国际

   食管是连接口腔和胃部的肌管。肌肉环的收缩和放松推动食物和液体通过食管的上段和下段。 Share · Tweet; WeChat. WeChat. Close. Weibo. April 04, 2025 ...

6. 血液科- 主治 - 妙佑医疗国际

   血液科——了解妙佑医疗国际创新的血液疾病（包括癌症）诊断和治疗方案。

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...